IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense®

IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical ...
MedPage Today

FDA Says Yes to Cryoablation for Early Breast Cancer

The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older women not suitable for surgery, maker IceCure announced. A minimally invasive ...
FierceBiotech

IceCure Medical stock jumps as FDA greenlights breast cancer cryoablation treatment

IceCure Medical’s tumor-freezing treatment ProSense has nabbed FDA approval, making it the first medical device of its kind to be endorsed for the local treatment of breast cancer. The Israeli medical ...
Bizcommunity on MSN

Steve Biko Academic Hospital performs pioneering cryoablation procedure

The Gauteng MEC for Health & Wellness, Nomantu Nkomo-Ralehoko, announced on X (Twitter) that the Steve Biko Academic Hospital in Pretoria recently achieved a South African public health milestone when ...